Your browser doesn't support javascript.
loading
Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.
Orr, Catherine; Spechler, Philip; Cao, Zhipeng; Albaugh, Matthew; Chaarani, Bader; Mackey, Scott; D'Souza, Deepak; Allgaier, Nicholas; Banaschewski, Tobias; Bokde, Arun L W; Bromberg, Uli; Büchel, Christian; Burke Quinlan, Erin; Conrod, Patricia; Desrivières, Sylvane; Flor, Herta; Frouin, Vincent; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Martinot, Jean-Luc; Martinot, Marie-Laure Paillère; Nees, Frauke; Papadopoulos Orfanos, Dimitri; Paus, Tomás; Poustka, Luise; Millenet, Sabina; Fröhner, Juliane H; Radhakrishnan, Rajiv; Smolka, Michael N; Walter, Henrik; Whelan, Robert; Schumann, Gunter; Potter, Alexandra; Garavan, Hugh.
Afiliação
  • Orr C; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405, corr@swin.edu.au.
  • Spechler P; Department of Psychological Sciences, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.
  • Cao Z; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
  • Albaugh M; Department of Psychology, University College Dublin, Dublin 4, Ireland.
  • Chaarani B; Department of Psychology and Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.
  • Mackey S; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
  • D'Souza D; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
  • Allgaier N; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
  • Banaschewski T; Department of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516.
  • Bokde ALW; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
  • Bromberg U; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Büchel C; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.
  • Burke Quinlan E; University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Conrod P; University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Desrivières S; Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, WC2R 2LS United Kingdom.
  • Flor H; Centre de recherche du CHU Ste-Justine and.
  • Frouin V; Department of Psychiatry, Université de Montréal, 3175 Chemin de la Côte Sainte-Catherine, Montreal, Québec H3T 1C5, Canada.
  • Gowland P; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, Addiction Sciences Building, London SE5 8BB, United Kingdom.
  • Heinz A; Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, WC2R 2LS United Kingdom.
  • Ittermann B; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Martinot JL; Department of Psychology, School of Social Sciences, University of Mannheim, 68131 Mannheim, Germany.
  • Martinot MP; NeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
  • Nees F; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, NG7 2RD United Kingdom.
  • Papadopoulos Orfanos D; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Paus T; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany, Berlin, 10587 Germany.
  • Poustka L; Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud-University Paris Saclay, DIGITEO Labs, 91190 Gif sur Yvette, France.
  • Millenet S; Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", and AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, 75014 Paris, France.
  • Fröhner JH; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Radhakrishnan R; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Smolka MN; NeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
  • Walter H; Rotman Research Institute, Baycrest, and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario M6A 2E1, Canada.
  • Whelan R; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, 37075, Göttingen, Germany.
  • Schumann G; Clinic for Child and Adolescent Psychiatry, Medical University of Vienna, 1090, Vienna, Austria, and.
  • Potter A; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Garavan H; Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, 01069 Germany.
J Neurosci ; 39(10): 1817-1827, 2019 03 06.
Article em En | MEDLINE | ID: mdl-30643026

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fumar Maconha / Substância Cinzenta Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fumar Maconha / Substância Cinzenta Idioma: En Ano de publicação: 2019 Tipo de documento: Article